When More Prescriptions Mean Less Clarity: Understanding the Risks of Polypharmacy

There is a quiet assumption embedded in modern healthcare: more treatment means more progress. When a symptom appears, a prescription follows. When a side effect surfaces, another medication is sometimes added to manage it. Over months and years, a patient who once took one or two medications may find themselves managing five, eight, or even a dozen different drugs simultaneously. In the medical community, this phenomenon has a name—polypharmacy—and it deserves far more scrutiny than it typically receives.

As a physician, I have sat across from patients who arrived carrying a paper bag filled with prescription bottles, genuinely uncertain which drug was doing what. That uncertainty is not a personal failure. It is often the predictable outcome of a fragmented healthcare system in which multiple specialists, each operating within their own clinical lane, prescribe independently without full visibility into the broader picture. The result can be a pharmacological landscape so layered that the original condition becomes difficult to see at all.

What Polypharmacy Actually Looks Like in Practice

Polypharmacy is generally defined as the concurrent use of five or more medications, though some clinical frameworks set the threshold even lower. Among adults over 65 in the United States, studies suggest that nearly 40 percent meet this definition. The figure is striking, but the more important question is not how many medications a person takes—it is whether each one continues to serve a clear, necessary, and safe purpose.

Consider a patient I will call Margaret, a 71-year-old woman referred to my practice after years of managing fatigue, mild cognitive difficulties, and recurring dizziness. Her medication list included a beta-blocker for hypertension, a proton pump inhibitor for acid reflux, a benzodiazepine for anxiety, a statin for cholesterol, a sleep aid, and an antihistamine she had been taking for years for what was labeled seasonal allergies. On paper, every drug had a rationale. In practice, the combination was quietly undermining her quality of life.

The benzodiazepine and sleep aid together were contributing to her cognitive fog. The antihistamine—one with sedating properties—was compounding both. Her dizziness, which had prompted a cardiology referral, was consistent with the hypotensive effects of her beta-blocker interacting with her blood pressure dropping further at night. None of these issues were exotic or rare. They were the predictable pharmacological arithmetic of too many drugs operating in the same system at the same time.

The Masking Effect: When Drugs Hide the Real Diagnosis

One of the most underappreciated risks of polypharmacy is not just what medications do to the body—it is what they prevent clinicians from seeing. When a drug suppresses a symptom without resolving its cause, the underlying condition may quietly progress while the patient and provider both believe the situation is managed.

Acid-suppressing medications are a useful example. Proton pump inhibitors are among the most commonly prescribed drugs in the country. They are effective at reducing stomach acid and relieving heartburn symptoms. They are also, in some patients, masking early gastrointestinal pathology that warrants investigation. A patient whose reflux symptoms are chemically silenced may never be referred for an upper endoscopy that could detect Barrett's esophagus or, in rarer cases, early malignancy.

Similarly, pain medications—particularly in patients managing chronic musculoskeletal complaints—can obscure the progression of inflammatory conditions such as rheumatoid arthritis or ankylosing spondylitis. When pain is the primary signal that something is wrong, consistently suppressing that signal without addressing its origin is not treatment. It is, at best, a temporary accommodation.

This is not an argument against symptom management. There are absolutely clinical circumstances in which controlling a symptom is the right and compassionate course of action. The concern arises when symptom control becomes a substitute for diagnostic inquiry.

Drug-Drug Interactions and the Cascade Prescription

Another dimension of polypharmacy that warrants attention is the cascade prescription—a pattern in which the side effect of one medication is interpreted as a new symptom and treated with an additional drug. The loop can continue indefinitely if no one steps back to evaluate the full picture.

A common example involves nonsteroidal anti-inflammatory drugs (NSAIDs). A patient taking NSAIDs for joint pain may develop elevated blood pressure as a side effect. That blood pressure elevation prompts the addition of an antihypertensive. The antihypertensive causes ankle swelling. The swelling is addressed with a diuretic. The diuretic leads to electrolyte imbalances. Each step made clinical sense in isolation. Together, they represent a chain of prescribing decisions that might have been avoided by reconsidering the original NSAID or exploring alternative pain management strategies.

Pharmacists and pharmacologists refer to drug-drug interactions as one of the leading contributors to preventable adverse drug events in the United States. The risk increases nonlinearly with the number of medications involved—meaning that going from four to five drugs is not simply adding 20 percent more risk. The interaction potential compounds in ways that are difficult to predict without systematic review.

Having the Medication Conversation With Your Physician

If you are taking multiple medications and have never had a comprehensive review of your full regimen, that conversation is worth initiating. It does not require a confrontational stance or suspicion of your prescribers. It requires a straightforward, collaborative inquiry into whether every drug on your list continues to serve you.

Here are some questions that can guide a productive discussion:

• What is the specific indication for each medication I am taking? Every drug should have a clear, current reason for being on your list. If you cannot articulate it—or if your physician struggles to—that is a signal worth exploring.

• Have any of my conditions resolved or changed in ways that might make a medication unnecessary? Many drugs are initiated for acute conditions and continued indefinitely through inertia rather than ongoing clinical need.

• Are any of my current symptoms potentially caused by a medication rather than a new condition? This question alone can redirect a clinical workup and prevent unnecessary additional prescribing.

• Is there a lower-risk alternative to any drug on this list? Pharmaceutical options evolve. A medication that was first-line therapy five years ago may now have a safer equivalent.

• Who is responsible for reviewing my full medication list? In a fragmented care model, this accountability can fall through the cracks. Identifying a primary coordinator—whether your internist, family physician, or a clinical pharmacist—matters.

The Value of a Medication Audit

A formal medication review, sometimes called a medication reconciliation or deprescribing consultation, is a structured process in which a clinician examines every drug a patient is taking, assesses continued necessity, identifies interactions, and proposes a rationalized regimen. In my practice, these reviews frequently surface surprises—drugs prescribed years ago for conditions that have since resolved, duplications across therapeutic classes, and interactions that were contributing to symptoms attributed to aging or unrelated illness.

Deprescribing—the intentional, supervised reduction or discontinuation of medications that are no longer appropriate—is an evidence-based practice with a growing body of research supporting its safety and benefit, particularly in older adults. It is not about minimizing treatment. It is about ensuring that every intervention a patient undergoes is earning its place in their care plan.

The goal of medicine has never been to add prescriptions indefinitely. It has always been to restore and preserve health with as much precision and as little unnecessary burden as possible. If your medication list has grown over the years without a corresponding conversation about whether it still reflects your current needs, that conversation is long overdue. I encourage you to start it.